){kind=logo}
Loeb & Loeb represented Agile Therapeutics, a women’s health care company, in a definitive merger with Insud Pharma, a global pharmaceutical group.
The acquisition has an estimated value of $45 million and is expected to close in the third quarter of 2024.
The acquisition has an estimated value of $45 million and is expected to close in the third quarter of 2024.